Check out our most popular compounded medications! Get Started
Bayview Pharmacy's compounded Misoprostol 0.0024%/Metronidazole 2%/Lidocaine HCl 2% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, targeting treatment or absorption of active ingredients in a gel-like consistency. It is used to treat various skin conditions such as rosacea, acne, perioral dermatitis, erythema, and folliculitis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy's Misoprostol 0.0024%/Metronidazole 2%/Lidocaine HCl 2% Topical Gel is a specially compounded medication designed to address a range of skin conditions. This unique formulation brings together the therapeutic benefits of three active ingredients, each playing a crucial role in alleviating symptoms and promoting skin health.
Misoprostol, a prostaglandin E1 analog, works to reduce inflammation and itching, providing relief for irritated skin. Metronidazole, an antibiotic, aids in combating bacterial infections and further reducing inflammation. Lidocaine HCl, a local anesthetic, helps to alleviate pain, making this formulation a comprehensive solution for skin discomfort.
This topical gel is indicated for the treatment of various skin conditions, including acne, rosacea, and dermatitis. Furthermore, it can be used to manage itching, burning, and pain associated with these conditions, providing comprehensive relief.
Dispensed through a pump mechanism, this semisolid formulation allows for easy and precise application on the skin, ensuring targeted treatment or absorption of active ingredients. The gel-like consistency ensures a smooth application process, making it user-friendly and efficient.
Bayview Pharmacy's Misoprostol 0.0024%/Metronidazole 2%/Lidocaine HCl 2% Topical Gel is a appropriate treatment option for patients suffering from various skin conditions. It is recommended that patients adhere to their healthcare provider's instructions for use and reach out to their provider with any questions or concerns.
Healthcare providers are encouraged to consider this unique formulation as a treatment option for their patients with skin conditions. For any queries about this formulation, please feel free to contact us.
This Misoprostol 0.0024%/Metronidazole 2%/Lidocaine HCl 2% Topical Gel is a compounded formulation designed for targeted treatment of various skin conditions. Additionally, it can be used to treat bacterial skin infections, including impetigo and folliculitis.
The combination of Misoprostol and Metronidazole in the formulation works synergistically to reduce inflammation and inhibit bacterial growth. Lidocaine HCl is included for its analgesic properties, providing relief from pain and itching associated with these skin conditions.
It is crucial to note that this formulation should not be applied to broken or damaged skin, or areas infected with viruses, such as cold sores or genital herpes. It is also not suitable for use in the eyes, nose, or mouth.
Patients are advised to apply a thin layer of the gel to the affected skin area two to three times daily, or as directed by their healthcare provider. The gel should be gently massaged into the skin until fully absorbed. After application, hands should be washed thoroughly to avoid accidental contact with the eyes, nose, and mouth.
Patients should be monitored for signs of an allergic reaction, such as rash, hives, itching, difficulty breathing, or swelling of the face, lips, tongue, or throat. If any of these symptoms occur, use of the gel should be discontinued immediately and the healthcare provider should be contacted.
Patients should also be advised to avoid exposure to sunlight or artificial UV light while using this formulation, as it may increase the risk of sunburn. If you have any questions about this formulation or its use, please reach out to your healthcare provider.
Misoprostol 0.0024%/Metronidazole 2%/Lidocaine HCl 2% Topical Gel is a compounded formulation that combines three potent active ingredients to effectively treat a range of skin conditions. Misoprostol, a prostaglandin E1 analog, plays a crucial role in reducing inflammation and pain. Metronidazole, an antibiotic, curbs the growth of bacteria on the skin, while Lidocaine HCl, a local anesthetic, alleviates pain and discomfort. This unique blend of ingredients works synergistically to reduce inflammation, pain, and bacterial growth on the skin.
When applied topically, Misoprostol 0.0024%/Metronidazole 2%/Lidocaine HCl 2% Topical Gel targets the affected area, reducing inflammation, pain, and bacterial growth.
To use this topical gel, apply a thin layer to the affected skin area as per the instructions provided by your healthcare provider. It is crucial not to exceed the recommended amount. Avoid contact with the eyes, nose, and mouth. If you experience any irritation or discomfort, discontinue use and consult your healthcare provider immediately.
Misoprostol 0.0024%/Metronidazole 2%/Lidocaine HCl 2% Topical Gel is a appropriate treatment option for various skin conditions. It is designed to reduce inflammation, pain, and bacterial growth on the skin. If you have any questions or concerns about using this product, please consult your healthcare provider.
This is a compounded formulation of three active ingredients: Misoprostol, Metronidazole, and Lidocaine HCl. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
This gel is designed for targeted treatment or absorption of its active ingredients. The specific conditions it treats will depend on the individual patient's needs and the prescribing doctor's discretion.
This gel should be applied to the skin as directed by your healthcare provider. It is dispensed through a pump mechanism for easy and precise application.
The active ingredients in this gel are Misoprostol, Metronidazole, and Lidocaine HCl.
This gel has a semisolid, gel-like consistency.
This gel is intended for topical use, but the specific area of application will depend on your healthcare provider's instructions. Always follow your healthcare provider's directions.
If you experience any side effects, contact your healthcare provider immediately. They can provide guidance on how to manage these side effects and determine whether you should continue using the gel.
Store this gel as directed by your healthcare provider or pharmacist. Typically, it should be stored at room temperature, away from heat and direct light.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Before using this gel, inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. They will be able to advise you on whether it is safe for you to use.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
